Optegra first to use cataract laser in UK

Article

Optegra is the first to offer the LensAR cataract laser in its London eye hospital.

Optegra is the first to offer the LensAR cataract laser in its London eye hospital.

The LensAR system, launched by Topcon, will be operated by a team of consultant ophthalmic surgeons led by Director of Laser Cataract Surgery for Optegra, Sundeep Kheterpal.

CE-marked and user-friendly, the system has a servo-controlled docking system that features a 'no corneal touch' liquid patient interface. This reportedly improves patient comfort and avoids compression and distortion to the cornea.

Mr Kheterpal commented, "Optegra has invested in this latest equipment to ensure we continue to offer the best possible service to our patients. Suitable for treatment of patients having both cataract surgery and Clarivu permanent lens replacement, the LensAR system has been designed to enhance the accuracy of surgery."

"The advantages of LensAR include full 3D custom imaging (CSI) of each individual eye, both posterior and anterior, to ensure precision and reproducibility. This enables the laser technology to perform laser incisions, which are more consistent and precise than ever before. The imaging is fully automated and there are multiple screens for ultimate accuracy and detail, leading to a most highly-informed diagnosis and accurate surgical procedure."

Optometrists and physicians wishing to offer their patients this cataract laser treatment are welcome to contact Hospital Manager Farzam Jafari, Optegra Eye Hospital, London, on +44 800 358 0825.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.